BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Change in the Number of New York Academy of Sciences Shares


1/31/2008 8:54:27 AM

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: As of 31 January 2008, the number of shares in Meda AB (STO:MEDAA) is 259,065,485, which constitutes a 2,386,134 increase in shares compared with the previous month. The increase is due to newly issued shares via redemption of warrants, exercised primarily by Stena Sessan Rederi AB. After the warrants redemption, the Stena Sessan Group's 1) shareholding rose to 67,151,652, which is comparable to 25.9% of Meda's share capital and votes. An additional 905,432 new shares can be subscribed for via redemption of warrants. If fully exercised, the dilution effect of Meda's share capital and votes is 0.03%. The warrant program ends on 26 February 2008.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->